Status:
TERMINATED
Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Melanosis
Eligibility:
FEMALE
18-75 years
Phase:
PHASE4
Brief Summary
Melasma is an acquired disorder of pigmentation that leads to irregular pigmented patches on the face. Treatment is difficult and to date the best treatment option is the combination of hydroquinone, ...
Eligibility Criteria
Inclusion
- Pregnant women or breastfeeding.
- Skin type 5 or 6.
Exclusion
- Known allergy to the compounds of the Kligman preparation.
- Refusal to put very high protection sunscreen during the study.
- Concomitant use of topical products that might have an effect on melasma (topical steroids, retinoids, etc…)
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00863278
Start Date
March 1 2009
End Date
December 1 2010
Last Update
March 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez
Nice, Alpes-Maritimes, France, 06001